Cargando…
Subclinical inflammation, telomere shortening, homocysteine, vitamin B6, and mortality: the Ludwigshafen Risk and Cardiovascular Health Study
PURPOSE: Short telomeres and B vitamin deficiencies have been proposed as risk factors for age-related diseases and mortality that interact through oxidative stress and inflammation. However, available data to support this concept are insufficient. We aimed to investigate the predictive role of B vi...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7230054/ https://www.ncbi.nlm.nih.gov/pubmed/31129702 http://dx.doi.org/10.1007/s00394-019-01993-8 |
_version_ | 1783534871149281280 |
---|---|
author | Pusceddu, Irene Herrmann, Wolfgang Kleber, Marcus E. Scharnagl, Hubert Hoffmann, Michael M. Winklhofer-Roob, Brigitte M. März, Winfried Herrmann, Markus |
author_facet | Pusceddu, Irene Herrmann, Wolfgang Kleber, Marcus E. Scharnagl, Hubert Hoffmann, Michael M. Winklhofer-Roob, Brigitte M. März, Winfried Herrmann, Markus |
author_sort | Pusceddu, Irene |
collection | PubMed |
description | PURPOSE: Short telomeres and B vitamin deficiencies have been proposed as risk factors for age-related diseases and mortality that interact through oxidative stress and inflammation. However, available data to support this concept are insufficient. We aimed to investigate the predictive role of B vitamins and homocysteine (HCY) for mortality in cardiovascular patients. We explored potential relationships between HCY, B vitamins, relative telomere length (RTL), and indices of inflammation. METHODS: Vitamin B6, HCY, interleukin-6 (IL-6), high-sensitive-C-reactive protein (hs-CRP), and RTL were measured in participants of the Ludwigshafen Risk and Cardiovascular Health Study. Death events were recorded over a median follow-up of 9.9 years. RESULTS: All-cause mortality increased with higher concentrations of HCY and lower vitamin B6. Patients in the 4th quartile of HCY and vitamin B6 had hazard ratios (HR) for all-cause mortality of 2.77 (95% CI 2.28–3.37) and 0.41(95% CI 0.33–0.49), respectively, and for cardiovascular mortality of 2.78 (95% CI 2.29–3.39) and 0.40 (95% CI 0.33–0.49), respectively, compared to those in the 1st quartile. Multiple adjustments for confounders did not change these results. HCY and vitamin B6 correlated with age-corrected RTL (r = − 0.086, p < 0.001; r = 0.04, p = 0.031, respectively), IL-6 (r = 0.148, p < 0.001; r = − 0.249, p < 0.001, respectively), and hs-CRP (r = 0.101, p < 0.001; r = − 0.320, p < 0.001, respectively). Subjects with the longest telomeres had a significantly higher concentration of vitamin B6, but lower concentrations of HCY, IL-6, and hs-CRP. Multiple regression analyses identified HCY as an independent negative predictor of age-corrected RTL. CONCLUSIONS: In conclusion, hyperhomocysteinemia and vitamin B6 deficiency are risk factors for death from any cause. Hyperhomocysteinemia and vitamin B6 deficiency correlate with increased mortality. This correlation might, at least partially, be explained by accelerated telomere shortening induced by oxidative stress and systemic inflammation in these circumstances. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00394-019-01993-8) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-7230054 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-72300542020-05-18 Subclinical inflammation, telomere shortening, homocysteine, vitamin B6, and mortality: the Ludwigshafen Risk and Cardiovascular Health Study Pusceddu, Irene Herrmann, Wolfgang Kleber, Marcus E. Scharnagl, Hubert Hoffmann, Michael M. Winklhofer-Roob, Brigitte M. März, Winfried Herrmann, Markus Eur J Nutr Original Contribution PURPOSE: Short telomeres and B vitamin deficiencies have been proposed as risk factors for age-related diseases and mortality that interact through oxidative stress and inflammation. However, available data to support this concept are insufficient. We aimed to investigate the predictive role of B vitamins and homocysteine (HCY) for mortality in cardiovascular patients. We explored potential relationships between HCY, B vitamins, relative telomere length (RTL), and indices of inflammation. METHODS: Vitamin B6, HCY, interleukin-6 (IL-6), high-sensitive-C-reactive protein (hs-CRP), and RTL were measured in participants of the Ludwigshafen Risk and Cardiovascular Health Study. Death events were recorded over a median follow-up of 9.9 years. RESULTS: All-cause mortality increased with higher concentrations of HCY and lower vitamin B6. Patients in the 4th quartile of HCY and vitamin B6 had hazard ratios (HR) for all-cause mortality of 2.77 (95% CI 2.28–3.37) and 0.41(95% CI 0.33–0.49), respectively, and for cardiovascular mortality of 2.78 (95% CI 2.29–3.39) and 0.40 (95% CI 0.33–0.49), respectively, compared to those in the 1st quartile. Multiple adjustments for confounders did not change these results. HCY and vitamin B6 correlated with age-corrected RTL (r = − 0.086, p < 0.001; r = 0.04, p = 0.031, respectively), IL-6 (r = 0.148, p < 0.001; r = − 0.249, p < 0.001, respectively), and hs-CRP (r = 0.101, p < 0.001; r = − 0.320, p < 0.001, respectively). Subjects with the longest telomeres had a significantly higher concentration of vitamin B6, but lower concentrations of HCY, IL-6, and hs-CRP. Multiple regression analyses identified HCY as an independent negative predictor of age-corrected RTL. CONCLUSIONS: In conclusion, hyperhomocysteinemia and vitamin B6 deficiency are risk factors for death from any cause. Hyperhomocysteinemia and vitamin B6 deficiency correlate with increased mortality. This correlation might, at least partially, be explained by accelerated telomere shortening induced by oxidative stress and systemic inflammation in these circumstances. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00394-019-01993-8) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2019-05-25 2020 /pmc/articles/PMC7230054/ /pubmed/31129702 http://dx.doi.org/10.1007/s00394-019-01993-8 Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Contribution Pusceddu, Irene Herrmann, Wolfgang Kleber, Marcus E. Scharnagl, Hubert Hoffmann, Michael M. Winklhofer-Roob, Brigitte M. März, Winfried Herrmann, Markus Subclinical inflammation, telomere shortening, homocysteine, vitamin B6, and mortality: the Ludwigshafen Risk and Cardiovascular Health Study |
title | Subclinical inflammation, telomere shortening, homocysteine, vitamin B6, and mortality: the Ludwigshafen Risk and Cardiovascular Health Study |
title_full | Subclinical inflammation, telomere shortening, homocysteine, vitamin B6, and mortality: the Ludwigshafen Risk and Cardiovascular Health Study |
title_fullStr | Subclinical inflammation, telomere shortening, homocysteine, vitamin B6, and mortality: the Ludwigshafen Risk and Cardiovascular Health Study |
title_full_unstemmed | Subclinical inflammation, telomere shortening, homocysteine, vitamin B6, and mortality: the Ludwigshafen Risk and Cardiovascular Health Study |
title_short | Subclinical inflammation, telomere shortening, homocysteine, vitamin B6, and mortality: the Ludwigshafen Risk and Cardiovascular Health Study |
title_sort | subclinical inflammation, telomere shortening, homocysteine, vitamin b6, and mortality: the ludwigshafen risk and cardiovascular health study |
topic | Original Contribution |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7230054/ https://www.ncbi.nlm.nih.gov/pubmed/31129702 http://dx.doi.org/10.1007/s00394-019-01993-8 |
work_keys_str_mv | AT puscedduirene subclinicalinflammationtelomereshorteninghomocysteinevitaminb6andmortalitytheludwigshafenriskandcardiovascularhealthstudy AT herrmannwolfgang subclinicalinflammationtelomereshorteninghomocysteinevitaminb6andmortalitytheludwigshafenriskandcardiovascularhealthstudy AT klebermarcuse subclinicalinflammationtelomereshorteninghomocysteinevitaminb6andmortalitytheludwigshafenriskandcardiovascularhealthstudy AT scharnaglhubert subclinicalinflammationtelomereshorteninghomocysteinevitaminb6andmortalitytheludwigshafenriskandcardiovascularhealthstudy AT hoffmannmichaelm subclinicalinflammationtelomereshorteninghomocysteinevitaminb6andmortalitytheludwigshafenriskandcardiovascularhealthstudy AT winklhoferroobbrigittem subclinicalinflammationtelomereshorteninghomocysteinevitaminb6andmortalitytheludwigshafenriskandcardiovascularhealthstudy AT marzwinfried subclinicalinflammationtelomereshorteninghomocysteinevitaminb6andmortalitytheludwigshafenriskandcardiovascularhealthstudy AT herrmannmarkus subclinicalinflammationtelomereshorteninghomocysteinevitaminb6andmortalitytheludwigshafenriskandcardiovascularhealthstudy |